In just four weeks, GLP-1 medication starts to work by reducing appetite, increasing feelings of fullness, and improving blood sugar control
Patients beginning a medical weight loss or hormone optimization program often ask the same question: "How quickly will I see changes in my body?" The answer depends on the type of treatment
Hepatic lipid assays: Ex vivo hepatic tissue studies and hepatocyte cell-line work have documented retatrutide's effect on markers associated with non-alcoholic fatty liver models, including lipid droplet accumulation and markers of hepatic lipid flux
Central nervous system Several Sikiric studies have reported neuroprotective effects in models of stroke, spinal cord injury, and neuroinflammation
however, patients with severe neurological complications or critically low B12 status should be treated with i.m
This is especially important for patients with underlying health concerns or those seeking sustainable results